Global Antihypertensive Market Growth 2023-2029

Global Antihypertensive Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Antihypertensive Industry Forecast” looks at past sales and reviews total world Antihypertensive sales in 2022, providing a comprehensive analysis by region and market sector of projected Antihypertensive sales for 2023 through 2029. With Antihypertensive sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antihypertensive industry.

This Insight Report provides a comprehensive analysis of the global Antihypertensive landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antihypertensive portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Antihypertensive market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antihypertensive and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antihypertensive.

The global Antihypertensive market size is projected to grow from US$ 18830 million in 2022 to US$ 21960 million in 2029; it is expected to grow at a CAGR of 21960 from 2023 to 2029.

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.

This report presents a comprehensive overview, market shares, and growth opportunities of Antihypertensive market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antihypertensive market?

What factors are driving Antihypertensive market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antihypertensive market opportunities vary by end market size?

How does Antihypertensive break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.